FES avid pulmonary adenocarcinoma and confounding ER+ breast carcinoma

FES avid pulmonary adenocarcinoma and confounding ER+ breast carcinoma

Breast carcinomas are well known for expression of estrogen receptor (ER) however there are other malignancies that are also express ER, possibly confounding the diagnostic interpretation of 16α-[18F]fluoro-17β-estradiol (FES; Cerianna GE HealthCare) in patients with both ER+ breast carcinomas and o...

Full description

Saved in:
Bibliographic Details
Main Authors: Yousif M. Abdelmoneim, MD, Yanyan Lou, MD PhD, Pooja Advani, MD, Andras Khoor, MD PhD, Akash Sharma, MD, Ephraim E. Parent, MD PhD
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Radiology Case Reports
Subjects:
Estrogen receptor
FES
Pulmonary adenocarcinoma
Breast carcinoma
Online Access:http://www.sciencedirect.com/science/article/pii/S1930043324012214
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items